Paclitaxel-incorporated nanoparticles of hydrophobized polysaccharide and their antitumor activity

International Journal of Pharmaceutics

Volumn 433, Issue 1-2, 2012, Pages 121-128

  Lee, Sang Joon ^a,d   Hong, Gun Young ^b   Jeong, Young Il ^a   Kang, Mi Sun ^a   Oh, Jong Suk ^a,d   Song, Chae Eun ^c   Lee, Hyun Chul ^a,d  

^a Chonnam National University Medical School   (South Korea)

^b Gwangju Christian Hospital   (South Korea)

^c Korea Institute of Natural Science Inc   (South Korea)

^d Chonnam National University   (South Korea)

Author keywords

HCT116; Nanoparticles; Paclitaxel; Polysaccharide; Pullulan

Indexed keywords

NANOPARTICLE; PACLITAXEL; POLYSACCHARIDE; PULLULAN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARTICLE; BIOCOMPATIBILITY; CANCER GROWTH; CELL VIABILITY; COLON CARCINOMA; CONTROLLED STUDY; CYTOTOXICITY; DRUG DELIVERY SYSTEM; DRUG EFFICACY; ENCAPSULATION; HUMAN; HUMAN CELL; HYDROPHOBICITY; IN VITRO STUDY; IN VIVO STUDY; MALE; MOUSE; NONHUMAN; PARTICLE SIZE; PRIORITY JOURNAL; SUSTAINED DRUG RELEASE;

ACETIC ANHYDRIDES; ANIMALS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; CELL LINE; CELL LINE, TUMOR; CHEMICAL PRECIPITATION; COLONIC NEOPLASMS; DELAYED-ACTION PREPARATIONS; DRUG DELIVERY SYSTEMS; GLUCANS; HUMANS; MACROPHAGES; MALE; MICE; MICE, INBRED BALB C; MICE, NUDE; MICROSCOPY, ELECTRON; NANOPARTICLES; PACLITAXEL; PARTICLE SIZE; POLYSACCHARIDES; TIME FACTORS;

EID: 84862845545     PISSN: 03785173     EISSN: 18733476     Source Type: Journal    
DOI: 10.1016/j.ijpharm.2012.04.048     Document Type: Article

References (36)

1. Abed, A., Assoul, N., Ba, M., Derkaoui, S.M., Portes, P., Louedec, L., Flaud, P., Bataille, I., Letourneur, D., Meddahi-Pellé, A., 2011. Influence of polysaccharide composition on the biocompatibility of pullulan/dextran-based hydrogels. J. Biomed. Mater. Res. A 96, 535-542.
2. Ayame, H., Morimoto, N., Akiyoshi, K., 2008. Self-assembled cationic nanogels for intracellular protein delivery. Bioconjug. Chem. 19, 882-890. (Pubitemid 351614544)
3. Chen, D.B., Yang, T.Z., Lu, W.L., Zhang, Q., 2001. In vitro and in vivo study of two types of long-circulating solid lipid nanoparticles containing paclitaxel. Chem. Pharm. Bull. 49, 1444-1447. (Pubitemid 33043274)
4. Crown, J., O'Leary, M., 2000. The taxanes: an update. Lancet 355, 1176-1178. (Pubitemid 30172946)
5. Gogate, U.S., Schwartz, P.A., Agharkar, S.N., 2009. Effect of unpurified Cremophor EL on the solution stability of paclitaxel. Pharm. Dev. Technol. 14, 1-8.
6. Gref, R., Minamitake, Y., Peracchia, M.T., Trubetskoy, V., Torchilin, V., Langer, R., 1994. Biodegradable long-circulating polymeric nanospheres. Science 263, 1600-1603. (Pubitemid 24128361)
7. Greish, K., Nagamitsu, A., Fang, J., Maeda, H., 2005. Copoly(styrene-maleic acid)-pirarubicin micelles: high tumor-targeting efficiency with little toxicity. Bioconjug. Chem. 16, 230-236. (Pubitemid 40129698)
8. Huynh, N.T., Passirani, C., Saulnier, P., Benoit, J.P., 2009. Lipid nanocapsules: a new platform for nanomedicine. Int. J. Pharm. 379, 201-209.
9. Jain, T.K., Richey, J., Strand, M., Leslie-Pelecky, D.L., Flask, C.A., Labhasetwar, V., 2008. Magnetic nanoparticles with dual functional properties: drug delivery and magnetic resonance imaging. Biomaterials 29, 4012-4021.
10. Jeanes, A., 1977. Dextrans and pullulans: industrially significant. ACS Symp. Ser. 45, 284-298.
11. Jeong, Y.I., Na, H.S., Cho, K.O., Lee, H.C., Nah, J.W., Cho, C.S., 2009. Antitumor activity of adriamycin-incorporated polymeric micelles of poly(γ-benzyl L-glutamate)/ poly(ethylene oxide). Int. J. Pharm. 365, 150-156.
12. Jeong, Y.I., Na, H.S., Oh, J.S., Choi, K.C., Song, C.E., Lee, H.C., 2006. Adriamycin release from self-assembling nanospheres of poly(dl-lactide-co- glycolide)-grafted pullulan. Int. J. Pharm. 322, 154-160.
13. Jeong, Y.I., Seo, S.J., Park, I.K., Lee, H.C., Kang, I.C., Akaike, T., Cho, C.S., 2005. Cellular recognition of paclitaxel-loaded polymeric nanoparticles composed of poly(gamma-benzyl l-glutamate) and poly(ethylene glycol) diblock copolymer endcapped with galactose moiety. Int. J. Pharm. 296, 151-161. (Pubitemid 40693384)
14. Jung, S.W., Jeong, Y.I., Kim, S.H., 2003. Characterization of hydrophobized pullulan with various hydrophobicities. Int. J. Pharm. 254, 109-121.
15. Kim, S.C., Kim, D.W., Shim, Y.H., Bang, J.S., Oh, H.S., Wan Kim, S., Seo, M.H., 2001. In vivo evaluation of polymeric micellar paclitaxel formulation: toxicity and efficacy. J. Control. Release 72, 191-202. (Pubitemid 32522357)
16. Kratz, F., 2008. Albumin as a drug carrier: design of prodrugs, drug conjugates and nanoparticles. J. Control. Release 132, 171-183.
17. Kwon, G., Suwa, S., Yokoyama, M., Okano, T., Sakurai, Y., Kataoka, K., 1994. Enhanced tumor accumulation and prolonged circulation times of micelle-forming poly(ethylene oxide-aspartate) block copolymer-adriamycin conjugates. J. Control. Release 29, 17-23.
18. Li, H., Yang, J., Hu, X., Liang, J., Fan, Y., Zhang, X., 2011. Superabsorbent polysaccharide hydrogels based on pullulan derivate as antibacterial release wound dressing. J. Biomed. Mater. Res. A 98, 31-39.
19. Maeda, H., Wu, J., Sawa, T., Matsumura, Y., Hori, K., 2000. Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a review. J. Control. Release 65, 271-284. (Pubitemid 30122932)
20. Marchetti, P., Urien, S., Cappellini, G.A., Ronzino, G., Ficorella, C., 2002. Weekly administration of paclitaxel: theoretical and clinical basis. Crit. Rev. Oncol. Hematol. 44 (Suppl.), S3-S13. (Pubitemid 36194423)
21. Marques, A.P., Reis, R.L., Hunt, J.A., 2002. The biocompatibility of novel starch-based polymers and composites: in vitro studies. Biomaterials 23, 1471-1478. (Pubitemid 34037084)
22. Marupudi, N.I., Han, J.E., Li, K.W., Renard, V.M., Tyler, B.M., Brem, H., 2007. Paclitaxel: a review of adverse toxicities and novel delivery strategies. Expert Opin. Drug Saf. 6, 609-621. (Pubitemid 351308218)
23. Mekhail, T.M., Markman, M., 2002. Paclitaxel in cancer therapy. Expert Opin. Pharmacother. 3, 755-766. (Pubitemid 34649705)
24. Noguchi, Y., Wu, J., Duncan, R., Strohalm, J., Ulbrich, K., Akaike, T., Maeda, H., 1998. Early phase tumor accumulation of macromolecules: a great difference in clearance rate between tumor and normal tissues. Jpn. J. Cancer Res. 89, 307-314. (Pubitemid 28197296)
25. Na, H.S., Lim, Y.K., Jeong, Y.I., Lee, H.S., Lim, Y.J., Kang, M.S., Cho, C.S., Lee, H.C., 2010. Combination antitumor effects of micelle-loaded anticancer drugs in a CT-26 murine colorectal carcinoma cells. Int. J. Pharm. 383, 192-200.
26. Rekha, M.R., Sharma, C.P., 2009. Blood compatibility and in vitro transfection studies on cationically modified pullulan for liver cell targeted gene delivery. Biomaterials 30, 6655-6664.
27. Rowinsky, E.K., Donehower, R.C., 1995. Paclitaxel (taxol). N. Engl. J. Med. 332, 1004-1014.
28. Sizovs, A., McLendon, P.M., Srinivasachari, S., Reineke, T.M., 2010. Carbohydrate polymers for nonviral nucleic acid delivery. Top. Curr. Chem. 296, 131-190.
29. Sugahara, S., Kajiki, M., Kuriyama, H., Kobayashi, T.R., 2002. Paclitaxel delivery systems: the use of amino acid linkers in the conjugation of paclitaxel with carboxymethyldextran to create prodrugs. Biol. Pharm. Bull. 25, 632-641. (Pubitemid 39663261)
30. Tanaka, T., Fujishima, Y., Hanano, S., Kaneo, Y., 2004. Intracellular disposition of polysaccharides in rat liver parenchymal and nonparenchymal cells. Int. J. Pharm. 286, 9-17. (Pubitemid 39410469)
31. ten Tije, A.J., Verweij, J., Loos, W.J., Sparreboom, A., 2003. Pharmacological effects of formulation vehicles: implications for cancer chemotherapy. Clin. Pharmacokinet. 42, 665-685. (Pubitemid 36936530)
32. Van, S., Das, S.K., Wang, X., Feng, Z., Jin, Y., Hou, Z., Chen, F., Pham, A., Jiang, N., Howell, S.B., Yu, L., 2010. Synthesis, characterization, and biological evaluation of poly(L-γ-glutamyl-glutamine)-paclitaxel nanoconjugate. Int. J. Nanomed. 5, 825-837.
33. Yokoyama, M., Miyauchi, M., Yamada, N., Okano, T., Sakurai, Y., Kataoka, K., 1990. Characterization and anticancer activity of the micelle-forming polymeric anti-cancer drug adriamycin-conjugated poly(ethylene glycol)-poly(aspartic acid) block copolymer. Cancer Res. 50, 1693-1700. (Pubitemid 20098806)
34. Yokoyama, M., Okano, T., Sakurai, Y., Ekimoto, H., Shibazaki, C., Kataoka, K., 1991. Toxicity and antitumor activity against solid tumors of micelle-forming polymeric anticancer drug and its extremely long circulation in blood. Cancer Res. 51, 3229-3236.
35. Yuen, S., 1974. Pullulan and its applications. Process Biochem. 9, 7-9.
36. Zhao, D., Zhao, X., Zu, Y., Li, J., Zhang, Y., Jiang, R., Zhang, Z., 2010. Preparation, characterization, and in vitro targeted delivery of folate-decorated paclitaxel-loaded bovine serum albumin nanoparticles. Int. J. Nanomed. 5, 669-677.